EVE Health Group Ltd (ASX: EVE) Share Price and News

Price

$0.033

Movement

0.002 (+6.45%)

As at 3 Jul - Closed (20 mins delayed)

52 Week Range

$0.028 - $0.04

 
1 Year Return

-17.5%

EVE Health Group Ltd Chart and Price Data

$0.02
$0.03
$0.04
$0.05
$0.02
$0.03
$0.04
$0.05
$0.02
$0.03
$0.04
$0.05
$0.02
$0.03
$0.04
$0.05

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.63 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 246.21 million
Earnings per share -0.009
Dividend per share N/A
Year To Date Return -27.50%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-27.50%

Shares Outstanding

246.21 million

Earnings per share

-0.009

Share Price

$0.033

Day Change

0.002 (+6.45%)

52 Week Range

$0.028 - $0.04

Yesterday's Close

$0.031

Today's Open

$0.031

Days Range

$0.029 - $0.033

Volume

405,137

Avg. Volume (1 month)

670,575

Turnover

$12,470

As at 3 Jul - Closed

  • EVE Health Group Ltd (ASX: EVE)
    Latest News

    No posts found.

    EVE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    26th Jun 2025 2025-06-26T12:45:05 Application for quotation of securities - EVEYesNo12:45pm616k
    26th Jun 2025 2025-06-26T12:44:55 Completion of Share Purchase PlanYesNo12:44pm1127k
    17th Jun 2025 2025-06-17T13:41:45 Change of Director's Interest NoticeYesNo1:41pm2185k
    16th Jun 2025 2025-06-16T08:38:34 Prescribing Agreement for ED and Dysmenorrhea ProductsYesNo8:38am2175k
    13th Jun 2025 2025-06-13T11:23:32 EVE Investor WebinarYesNo11:23am1140k
    12th Jun 2025 2025-06-12T17:14:36 Ceasing to be a substantial holderYesNo5:14pm4312k
    12th Jun 2025 2025-06-12T17:14:11 Becoming a substantial holderYesNo5:14pm2202k
    12th Jun 2025 2025-06-12T17:11:41 Initial Director's Interest NoticeYesNo5:11pm2155k
    12th Jun 2025 2025-06-12T17:11:01 Final Director's Interest NoticeYesNo5:11pm2170k
    12th Jun 2025 2025-06-12T09:47:59 EVE Completes Nextract AcquisitionYesNo9:47am2171k

    About EVE Health Group Ltd

    EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. Its portfolio includes Omni Innovation, Meluka Australia, Jenbrook Australia, and Naturally Australian Products. It operates through the following segments: Jenbrook, Meluka, and Investment. The company was founded on October 1, 2003 and is headquartered in Subiaco, Australia.

    EVE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Jul 2025 $0.03 $0.00 0.00% 23,517 $0.03 $0.03 $0.03
    30 Jun 2025 $0.03 $0.00 0.00% 144,557 $0.03 $0.03 $0.03
    27 Jun 2025 $0.03 $0.00 0.00% 748,487 $0.03 $0.03 $0.03
    26 Jun 2025 $0.03 $0.00 0.00% 320,970 $0.03 $0.03 $0.03
    25 Jun 2025 $0.03 $0.00 0.00% 159,980 $0.03 $0.03 $0.03
    24 Jun 2025 $0.03 $0.00 0.00% 682,266 $0.04 $0.04 $0.03
    23 Jun 2025 $0.04 $0.00 0.00% 130,393 $0.03 $0.04 $0.03
    20 Jun 2025 $0.03 $0.00 0.00% 720,238 $0.03 $0.03 $0.03
    19 Jun 2025 $0.03 $0.00 0.00% 718,972 $0.03 $0.03 $0.03
    18 Jun 2025 $0.03 $0.00 0.00% 1,531,470 $0.03 $0.03 $0.03
    17 Jun 2025 $0.03 $0.00 0.00% 709,626 $0.04 $0.04 $0.03
    16 Jun 2025 $0.04 $0.00 0.00% 714,728 $0.04 $0.04 $0.03
    13 Jun 2025 $0.04 $0.00 0.00% 1,793,459 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Jun 2025 Stuart Gunzburg Buy 279,482 $8,963
    On-market trade.
    26 Nov 2024 Gregory Fry Expiry 16,000,000 $16,000
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Stuart Gunzburg Non-Executive Director Jun 2025
    --
    Mr Gregory William (Bill) Fry Executive DirectorChief Executive OfficerManaging Director Aug 2009
    Mr Fry has more than 20 years corporate experience in accounting, management, business development and general corporate activities. He has experience in project evaluation and development, project funding, management, finance and operations. Mr Fry has been on the board of several public and private companies across the sectors of agriculture, mining, property and funds management. Former directorship in the last three years was with Alma Metals Limited.
    Mr Rodney Andrew Hannington Non-Executive ChairmanNon-Executive Director Jun 2022
    Mr Hannington has been working in marketing and strategy services in consumer health and fast-moving consumer goods in the Asia Pacific region for over 15 years. He has international experience in markets across Australia, China, Japan, South Korea and Southeast Asia. Mr Hannington has been a member of the Monash University Department of Marketing Industry Advisory Board since 2013 and has held board roles at ASX listed companies, with a focus in the consumer health space.
    Mr Steven Jackson Company Secretary
    -
    Ben Rohr Chief Operating Officer
    -
    Steven Jackson Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Everhoney Biotech Australia Pty Ltd 660,522,752 12.52%
    Hong Kong Jusheng Bolang Technology Co Limited 507,488,612 9.62%
    Mr Alasdair Cooke (And Associated Entities) 348,039,268 6.60%
    Mr Honghao Sun 250,000,000 4.74%
    Mr Marc John Calokerinos 184,000,000 3.49%
    Terra Metallica Nominees Pty Ltd <Terra Metallica A/C> 136,000,000 2.58%
    Mr Benedict Rohr 111,900,000 2.12%
    Mr Gregory Fry (And Associated Entities) 86,604,729 1.64%
    Mr Miroslav Michael Petrovic 56,333,334 1.07%
    Mr Anthony John Andrews 50,030,000 0.95%
    Mrs Abigail Clare Fry 45,760,124 0.87%
    HSBC Custody Nominees (Australia) Limited 40,212,236 0.76%
    Bryan Kent Easson 35,530,000 0.67%
    Robyn Merryl Ingersole 35,530,000 0.67%
    Mr Steven Luke Jackson 33,662,524 0.64%
    Mr Richard Black 32,500,000 0.62%
    Mr Mark Burnell 32,161,202 0.61%
    Station Capital Pty Ltd 32,000,000 0.61%
    Citicorp Nominees Pty Limited 30,864,304 0.59%
    Mr Paul America 30,000,000 0.57%

    Profile

    since

    Note